Physician profile
Hasan Syed
NPI 1982816468
$1,630.29
in general payments reported to CMS, 2019-2025
9 companies · $586 in 2025
The $586 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $64.27 · 2021: $475 · 2022: $207 · 2023: $26.31 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.10 |
| Education | $144.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $529.10 | 2019-2025 | Comprehensive Shoulder System |
| Stryker Corporation | $453.05 | 2021 | |
| Moximed, INC | $180.87 | 2025 | Misha Knee System, Small, Left |
| Smith+Nephew, INC. | $179.00 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 7, Firstpass |
| Sportstek Medical, INC | $116.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $108.63 | 2025 | |
| Novo Nordisk INC | $23.26 | 2025 | |
| Janssen Pharmaceuticals, INC | $20.87 | 2025 | Spravato |
| Hydrocision, INC. | $18.97 | 2025 | Tenjet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasan Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.